Rheumatoid Arthritis Clinical Trials in Houston

Showing 2401-2420 of 3,412 trials

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

NCT02556177

This is an open-label, non-randomized, prospective, multi-site, parallel group (segment), hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical neuropsychological assessments and GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

ConcussionTraumatic Brain Injury

GE Healthcare477 participantsStarted Nov 2015

San Diego, California, United States • San Francisco, California, United States • Miami, Florida, United States +4 more locations

COMPLETEDPhase 1< 1 mile

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

NCT02307240

This is a Phase I, open-label, multi-center trial designed to evaluate the safety, tolerability and pharmacokinetics of CUDC-907 administered orally to subjects with advanced/relapsed solid tumors.

Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more

Curis, Inc.43 participantsStarted Nov 2014

San Francisco, California, United States • Sarasota, Florida, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

NCT01447914

This phase II trial studies the side effects and how well tivantinib works in treating patients with relapsed, or relapsed and refractory multiple myeloma. Tivantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Refractory Multiple Myeloma

National Cancer Institute (NCI)16 participantsStarted Nov 2011

Houston, Texas, United States

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Rheumatoid Arthritis Trials in Other Cities

Primary Mitral Regurgitation Repair

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Reevaluation Of Systemic Early Neuromuscular Blockade

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Other Conditions in Houston